Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
200 participants
INTERVENTIONAL
2014-06-30
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Physical Activity Maintenance of Cancer Survivors
NCT03976193
Physical Activity for Campus Employees
NCT01617499
Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors
NCT07215091
Physical Activity Intervention for Lung Cancer Survivors
NCT00717795
Alberta Cancer Exercise Pilot Randomized Trial
NCT02330575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Procedures
1. UW WELL-FIT advertisement for Grand River Regional Cancer Centre
2. UW WELL-FIT brochure
3. Referral Form
4. Participants initial consultation and assessment
5. Obtain consent for UW WELL-FIT
6. Obtain Participant Information
7. Completion of FACIT-F survey
8. Metabolism \& Body Composition - Information sheet for optional measures
9. Physical Activity Survey- Godin Questionnaire
10. Provide 3-Day food diary and Nutritional Assessment
11. Fitness assessment, exercise programming and data entry:
1. Submaximal cardiovascular cycle ergometer or treadmill graded exercise test
2. Muscular strength using force transducer
3. Body composition:
* Height, weight and waist girth
* Bioelectrical Impedance Analysis (BIA)
* Dual Energy X-ray Absorption (Optional)
4. Range of motion using a goniometer
5. Blood sampling (Optional)
6. Design Individualized exercise program
12. UW WELL-FIT - Commencement of participant in 12 week exercise program (2 x 60 minute classes)
13. Post assessment (repeated pre-test assessments)
14. Pre and post data are entered into database
15. Summary and Feedback Report
16. Graduate Program: participant selects to attend UW WELL-FIT Graduate Program
17. Participants have annual reassessments in the Graduate Program
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiovascular and strength training exercise
24 sessions (\~12 weeks) exercise
Exercise
Cardiovascular and resistance exercise training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Cardiovascular and resistance exercise training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Waterloo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julia Fraser
Research and Operations Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caryl Russell, MSc
Role: PRINCIPAL_INVESTIGATOR
University of Waterloo
Michael Sharratt, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Waterloo
Marina Mourtzakis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Waterloo
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORE18987-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.